Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes

Cristina Hernández, Marta García-Ramírez, Lidia Corraliza, Jimena Fernández-Carneado, Josep Farrera-Sinfreu, Berta Ponsati, Águeda González-Rodríguez, Ángela M. Valverde, Rafael Simó

Research output: Contribution to journalArticleResearchpeer-review

74 Citations (Scopus)


Retinal neurodegeneration is an early event in the pathogenesis of diabetic retinopathy (DR). Somatostatin (SST) is an endogenous neuroprotective peptide that is downregulated in the diabetic eye. The aim of the study was to test the usefulness of topical administration of SST in preventing retinal neurodegeneration. For this purpose, rats with streptozotocin-induced diabetes mellitus (STZ-DM) were treated with either SST eye drops or vehicle for 15 days. Nondiabetic rats treated with vehicle served as a control group. Functional abnormalities were assessed by electroretinography (ERG), and neurodegeneration was assessed by measuring glial activation and the apoptotic rate. In addition, proapoptotic (FasL, Bid, and activation of caspase-8 and caspase-3) and survival signaling pathways (BclxL) were examined. Intraretinal concentrations of glutamate and its main transporter glutamate/aspartate transporter (GLAST) were also determined. Treatment with SST eye drops prevented ERG abnormalities, glial activation, apoptosis, and the misbalance between proapoptotic and survival signaling detected in STZ-DM rats. In addition, SST eye drops inhibited glutamate accumulation in the retina and GLAST downregulation induced by diabetes mellitus. We conclude that topical administration of SST has a potent effect in preventing retinal neurodegeneration induced by diabetes mellitus. In addition, our findings open up a new preventive pharmacological strategy targeted to early stages of DR. © 2013 by the American Diabetes Association.
Original languageEnglish
Pages (from-to)2569-2578
Issue number7
Publication statusPublished - 1 Jul 2013

Fingerprint Dive into the research topics of 'Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes'. Together they form a unique fingerprint.

Cite this